According to Science|Business, the EU is considering mechanisms to manage the increasingly low EU grant success rates before research universities shy away from the EU calls.
“It’s more popular than ever before. But with our success rates we’re heading to a situation where we have to be very careful not to scare away top researchers,” Robert-Jan Smits, the European Commission’s Director-General for Research and Innovation, told Science|Business.
Apparently, the Commission is considering three approaches:
- Two-stage applications – As a rule of thumb, 80 per cent of proposals – those not considered strong enough to meet competition requirements – should be rejected in a short-form, stage one evaluation, Smits said. In stage two, where a longer application is required, at least 35 per cent of proposals should have a chance of success.
- Greater emphasis on impact – Brendan Hawdon, Head of Horizon 2020 Policy in Smit’s directorate-general, elaborated. “It’s all about the outcome,” he said. An applicant should say clearly: “Here’s what we want to come out of the project.”
- Non-starters – making the call documents clearer so that potential applicants can work out for themselves that they will not be funded alongside, potentially, some element of demand management
To read this article in full, please go to Science|Business, where you can also register for newsletter updates.











Beyond Academia: Exploring Career Options for Early Career Researchers – Online Workshop
UKCGE Recognised Research Supervision Programme: Deadline Approaching
SPROUT: From Sustainable Research to Sustainable Research Lives
BRIAN upgrade and new look
Seeing the fruits of your labour in Bangladesh
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease